DoW Vision, Translational Research Award
Open Posted
- Opportunity number
- HT942526VRPTRA
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Unrestricted
- Points of contact
-
- eBRAP Help Desk help@ebrap.org (301) 682-5507
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Department of the Army Medical Command is soliciting applications for the fiscal year 2026 Vision Research Program Translational Research Award to fund translational research that transforms promising discoveries into new drugs, devices, or clinical practice guidelines ready for definitive testing in clinical trials, with a pre-application deadline of July 28, 2026 and full application due date of November 12, 2026. The program expects to allocate approximately $1.6 million to fund one award with a total cost cap of $1.6 million and a maximum period of performance of three years. No cost share is required.
Eligible applicants include unrestricted categories: extramural and intramural U.S. Department of War organizations, both domestic and foreign, as well as for-profit and nonprofit entities. If the research team is developing new drugs or devices, it must include expertise in the regulatory approval process. The Translational Research Award includes a Partnering Principal Investigator Option allowing for two PIs (an Initiating PI and a Partnering PI) with separate awards.
Research must align with at least one of three focus areas: understanding and treating eye injury or visual dysfunction related to military exposure; diagnosing, stabilizing, and treating eye injuries in austere and prolonged care settings; or restoring visual function after military-related vision loss. The award may support preclinical studies, clinical research, or a pilot clinical trial, but not a full-scale clinical trial. Applications proposing pilot clinical trials must also include non-PCT translational research components.
Peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, Personnel, and Post-Award Transition Plan. Programmatic review criteria include adherence to the intent of the TRA, contribution to the VRP portfolio, relative impact, and relevance to military health. The Defense Health Agency may share applications and reviews with the National Eye Institute for independent funding consideration. Peer review occurs in January 2027 and programmatic review in March 2027, with awards anticipated by September 30, 2027 using FY26 funds expiring for use on September 30, 2032. The Assistance Listing / CFDA number is 12.420 (Military Medical Research and Development).
Synopsis
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials during or by the end of the period of performance. The TRA may be used to support preclinical studies, clinical research or a pilot clinical trial, but not a full-scale clinical trial. Research must align with at least one of the FY26 VRP Focus Areas.
Distinctive Features:
· If developing new drugs or device(s), the research team must include expertise in the regulatory approval process.
· The TRA includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI.
· Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, Personnel and Post-Award Transition Plan.
· Programmatic review criteria include adherence to the intent of the TRA, contribution to the VRP portfolio, relative impact and relevance to military health.
· The VRP may share FY26 TRA applications and reviews with the National Eye Institute (NEI) for independent funding consideration.
https://cdmrp.health.mil/pubs/press/2026/vrppreann
Files
| File | Type | Posted |
|---|---|---|
| HT942526VRPTRA_GG.pdf | ||
| PKG00292677.pdf | ||
| FY2026 VRP PA Reference Table_Final.pdf | ||
| HT942526VRPTRA_GG.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity